HPV vaccine uptake in Pakistan: A qualitative study to identify barriers and facilitators before the first HPV national rollout.

Khola Noreen¹, Samina Naeem Khalid², Mehreen Noor¹, Saba Maryam¹, Abdul Momin Rizwan Ahmad^3,4, Nilab Mohammadi⁵

¹Department of Community Medicine & Public Health, Rawalpindi Medical University, Rawalpindi, Pakistan.

²School of Public Health, Health Services Academy, Islamabad, Pakistan.

³Department of Health Sciences, University of York, York, UK.

⁴Department of Human Nutrition & Dietetics, NUST School of Health Sciences, National University of Sciences & Technology (NUST), Islamabad, Pakistan.

⁵Department of Curative Medicine, Ghalib University, Herat, Afghanistan.

PubMed DOI

Abstract

Although vaccines remain a mainstay tool for the prevention of infectious diseases, their efficacy, safety, and trust among the population remain controversial. For an effective rollout of the HPV vaccine in Pakistan, financial constraints, health system fragility, and complex cultural values should be kept in mind, and these should be apprehended as both facilitators and barriers, since these fin…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.